StonvexLoading…
StonvexStonvexStonvexCore line items from ACNB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $50.51M | $191.82M | $144.63M | $93.73M |
Operating Income | $17.26M | $46.45M | $33.28M | $14.36M |
Net Income | $13.70M | $37.05M | $26.25M | $11.65M |
EPS (Diluted) | $1.32 | $3.60 | $2.56 | $1.12 |
Total Assets | $3.27B | $3.23B | $3.25B | $3.26B |
Total Liabilities | $2.84B | $2.81B | $2.84B | $2.86B |
Cash & Equivalents | $93.64M | $65.65M | $102.14M | $103.11M |
Free Cash Flow OCF − CapEx | $23.99M | $52.57M | $39.98M | $17.22M |
Shares Outstanding | 10.34M | 10.37M | 10.42M | 10.48M |